Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 209

    1.

    Role of endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomy.

    De León DD, Deng S, Madani R, Ahima RS, Drucker DJ, Stoffers DA.

    Diabetes. 2003 Feb;52(2):365-71.PMID: 12540609 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action.

    Scrocchi LA, Hill ME, Saleh J, Perkins B, Drucker DJ.

    Diabetes. 2000 Sep;49(9):1552-60.PMID: 10969840 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    beta-Cell Pdx1 expression is essential for the glucoregulatory, proliferative, and cytoprotective actions of glucagon-like peptide-1.

    Li Y, Cao X, Li LX, Brubaker PL, Edlund H, Drucker DJ.

    Diabetes. 2005 Feb;54(2):482-91.PMID: 15677506 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis.

    Li Y, Hansotia T, Yusta B, Ris F, Halban PA, Drucker DJ.

    J Biol Chem. 2003 Jan 3;278(1):471-8. Epub 2002 Oct 29.PMID: 12409292 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats.

    Xu G, Stoffers DA, Habener JF, Bonner-Weir S.

    Diabetes. 1999 Dec;48(12):2270-6.PMID: 10580413 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Identification of glucagon-like peptide 1 (GLP-1) actions essential for glucose homeostasis in mice with disruption of GLP-1 receptor signaling.

    Scrocchi LA, Marshall BA, Cook SM, Brubaker PL, Drucker DJ.

    Diabetes. 1998 Apr;47(4):632-9.PMID: 9568697 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4.

    Tourrel C, Bailbe D, Lacorne M, Meile MJ, Kergoat M, Portha B.

    Diabetes. 2002 May;51(5):1443-52.PMID: 11978641 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice.

    Hansotia T, Drucker DJ.

    Regul Pept. 2005 Jun 15;128(2):125-34. Review.PMID: 15780432 [PubMed - indexed for MEDLINE]Related articles

    11.

    Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.

    Drucker DJ.

    Mol Endocrinol. 2003 Feb;17(2):161-71. Review.PMID: 12554744 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Hormone-sensitive lipase has a role in lipid signaling for insulin secretion but is nonessential for the incretin action of glucagon-like peptide 1.

    Peyot ML, Nolan CJ, Soni K, Joly E, Lussier R, Corkey BE, Wang SP, Mitchell GA, Prentki M.

    Diabetes. 2004 Jul;53(7):1733-42.PMID: 15220197 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Glucagon-like peptide-1.

    Doyle ME, Egan JM.

    Recent Prog Horm Res. 2001;56:377-99. Review.PMID: 11237222 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    New developments in the biology of the glucagon-like peptides GLP-1 and GLP-2.

    Drucker DJ, Lovshin J, Baggio L, Nian M, Adatia F, Boushey RP, Liu Y, Saleh J, Yusta B, Scrocchi L.

    Ann N Y Acad Sci. 2000;921:226-32. Review.PMID: 11193827 [PubMed - indexed for MEDLINE]Related articles

    15.

    Targeted gene disruption in endocrine research--the case of glucagon-like peptide-1 and neuroendocrine function.

    Seeley RJ, Woods SC, D'Alessio D.

    Endocrinology. 2000 Feb;141(2):473-5. Review. No abstract available. PMID: 10650925 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Bioactive GLP-1 in gut, receptor expression in pancreas, and insulin response to GLP-1 in diabetes-prone rats.

    Valverde I, Wang GS, Burghardt K, Kauri LM, Redondo A, Acitores A, Villanueva-Peñacarrillo ML, Courtois P, Sener A, Cancelas J, Malaisse WJ, Scott FW.

    Endocrine. 2004 Feb;23(1):77-84.PMID: 15034199 [PubMed - indexed for MEDLINE]Related articles

    17.

    Transfection of pancreatic-derived beta-cells with a minigene encoding for human glucagon-like peptide-1 regulates glucose-dependent insulin synthesis and secretion.

    Hui H, Yu R, Bousquet C, Perfetti R.

    Endocrinology. 2002 Sep;143(9):3529-39. Erratum in: Endocrinology 2002 Nov;143(11):4349. PMID: 12193567 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.

    Baggio LL, Huang Q, Brown TJ, Drucker DJ.

    Gastroenterology. 2004 Aug;127(2):546-58.PMID: 15300587 [PubMed - indexed for MEDLINE]Related articles

    19.

    Physiology of GLP-1--lessons from glucoincretin receptor knockout mice.

    Thorens B.

    Horm Metab Res. 2004 Nov-Dec;36(11-12):766-70. Review.PMID: 15655706 [PubMed - indexed for MEDLINE]Related articles

    20.

    Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor.

    Cani PD, Knauf C, Iglesias MA, Drucker DJ, Delzenne NM, Burcelin R.

    Diabetes. 2006 May;55(5):1484-90.PMID: 16644709 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data